About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Organizations Butler
Research Type Clinical
Therapeutic Area of Study Parkinson's Disease/Movement Disorders
Principal Investigators
Eligibility Criteria Male or female subjects over the age of 40 with Parkinson’s disease and psychotic symptoms that developed after the diagnosis of PD that include; visual hallucinations and/or auditory hallucinations and/or delusions
Recruitment Status Open
Date Study Started 08/01/2010
Date Study Ends 08/01/2015
Contact Information

 For more information contact Lisa at 401-455-6667

Description The purpose of this study is to investigate the safety of Pimavanserin in the treatment of psychosis in Parkinson’s disease. The study is weeks long with 6 visits over the course of that time with the option to participate in an open-label extension study.
Look for another study
Health Headlines
Drug Gives 'New Hope' Against Heart Failure, Expert SaysView in a lightbox
Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency SaysView in a lightbox
Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken AmericansView in a lightbox
European MRSA Originated in Sub-Saharan Africa, Study FindsView in a lightbox
'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study FindsView in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices